New Cannabinoids: Where are They Coming From — & Which is Right for You?
Cannabis, also known as marijuana, has been used for centuries as a way to relax and relieve pain. However, more and more people are becoming interested in using cannabinoids – substances found in cannabis that are thought to have medicinal properties. In this D8 Super Store, we’ll take a look at where new cannabinoids are coming from, and what implications their widespread use might have on the world.
What is a Cannabinoid?
A cannabinoid is a chemical found in cannabis plants that produces a psychoactive effect. There are over 100 cannabinoids identified in cannabis, with THC being the most well-known.
While there are many cannabinoids present in cannabis, only a handful have been studied extensively and are known to produce psychoactive effects. These include THC, CBD, CBN, CBC, and many others. The cannabinoid profile of a given strain will vary depending on the cannabis genetics and growing conditions, so it’s important to experiment with different strains to find what works best for you.
Where are New Cannabinoids Coming From?
The U.S. Drug Enforcement Administration released a document in early March of this year outlining their concerns about the increasing production and availability of new cannabinoids, particularly cannabidiol (CBD) and its derivatives. The report claims that CBD is being produced in high quantities and used to circumvent laws prohibiting the use of other cannabinoids. The DEA report also claims that CBD is being sold as “legal marijuana” products across the United States.
The DEA report is based on data from customs seizures made between January 1st and December 31st of last year. Customs seizures are a good indicator of how much drugs are being trafficked across borders, but they don’t always reflect the true extent of drug availability. For example, seizures of synthetic cannabinoids may not necessarily indicate that these substances are being sold on the street.
Producers of new cannabinoids seem to be focusing on developing products with CBD as their main active ingredient. CBD has been shown to have a number of medical benefits, making it an attractive alternative to traditional medications. However, there are also a number of potential risks associated with using CBD products. For example, CBD can interact with other medications that people are taking, and it can also cause adverse effects when
Delta-8 THC’s Origin
Delta- THC is a new cannabinoid that is being developed by the pharmaceutical company, GW Pharmaceuticals.
Delta- THC is a synthetic cannabinoid that is derived from the psychoactive component of cannabis, THC. Delta- THC is intended to be used as a treatment for various medical conditions, including chronic pain and cancer pain.
The development of Delta- THC is important because it shows that there are new opportunities for cannabinoids to be developed and used as treatments. This suggests that there are many potential applications for cannabinoids beyond just recreational use.
Where Did THC-O Come From?
The psychoactive compound tetrahydrocannabinol, or THC, is the most well-known cannabinoid. It’s found in marijuana, and is responsible for the “high” people experience when using the plant. But THC isn’t the only cannabinoid out there. Researchers have been working on developing new cannabinoids for years, and some of them are starting to make their way into the mainstream. Here’s a look at some of the most interesting ones:
THC-O — This cannabinoid was first isolated from hemp plants in 1998. It has a different chemical makeup than THC, and doesn’t produce a psychoactive effect. Researchers are exploring its potential uses in medicine, including treatments for epilepsy and other conditions.
ACB — This cannabinoid was first isolated from a different type of cannabis in 2003. It’s considered to be more potent than THC, and has been shown to have therapeutic effects in studies involving cancer and other diseases.
CBG — This cannabinoid was first identified in 2006 and is mainly found in low concentrations in marijuana plants. However, it has been shown to have anti-inflammatory and analgesic properties, which could make it useful for treating a variety of conditions.
What About HHC?
The cannabis plant is known to contain more than 60 different cannabinoids, but only a handful of them have been studied extensively. In the past few years, new cannabinoids have been emerging and gaining attention. Some of these new compounds are called “hHCs” (hydrocannabidiols).
3 of the Best Cannabinoids & What They Can Do
Cannabinoids are a class of drugs that are derived from the cannabis plant. Cannabinoids have been shown to have a variety of health benefits, including reducing pain, fighting cancer, and improving anxiety and depression symptoms.
The cannabinoids found in cannabis plants are divided into two groups: primary and secondary. Primary cannabinoids are the compounds that are isolated from the plant itself, while secondary cannabinoids are created when the primary cannabinoids interact with other chemicals in the plant.
There are over 100 different cannabinoids present in cannabis plants, but only a few of these have been studied in detail. The most well-known cannabinoid is THC, which is responsible for the psychoactive effects of cannabis. Other well-known cannabinoids include CBD and CBC.
Most cannabinoid research has been focused on CBD and CBC because they are believed to have the most therapeutic potential. These cannabinoids can be used to treat a wide range of conditions, including chronic pain, anxiety disorders, and depression.
While more research is needed to confirm these findings, it seems clear that cannabinoids offer great potential for treating a wide range of health conditions.
Delta-8 THC
Delta- THC is a new type of cannabinoid that is being developed by the cannabis industry.
Delta- THC is a cannabinoid that is derived from the psychoactive plant, cannabis. Delta- THC is different than other cannabinoids because it does not produce a “high”. Instead, it is used to treat medical conditions such as anxiety and chronic pain.
Delta- THC has been shown to be effective in treating these conditions. It has also been shown to be safe and well-tolerated by patients.
Delta- THC is being developed by the cannabis industry as a new type of cannabinoid. It is different than other cannabinoids because it does not produce a “high”. This makes it a better choice for patients who are looking for a non-psychoactive cannabinoid to use.
THC-O Acetate
The CB1 and CB2 receptors are most active in the central nervous system and immune system, respectively. In order for cannabinoids to exert their effects in these areas, they must pass through the blood-brain barrier. This is where THC-O Acetate comes in: it is a pharmaceutical grade product that is able to cross the blood-brain barrier. This means that it can provide relief from conditions like chronic pain, anxiety, and inflammation.
HHC
The medical marijuana industry is booming, and with good reason. The proven benefits of cannabis for patients are undeniable, and there are now many different strains and varieties of cannabis available to choose from. But where did these new cannabinoids come from?
One popular source of cannabinoids is the cannabis plant’s flowers. These flowers contain a variety of different cannabinoids, including THC, CBD, and CBG. However, these cannabinoids are not unique to cannabis; they can also be found in other plants, such as hemp.
Researchers have been working hard to isolate these cannabinoids and create variants that are specific to cannabis. This process is called “decarboxylation,” and it involves heating the cannabinoid until it turns into a psychoactive compound.
Some companies are already using decarboxylated cannabinoids in their products. GW Pharmaceuticals has developed a drug called Sativex that uses decarboxylated THC to treat pain symptoms in patients with multiple sclerosis. Novartis has created a drug called Nuedexta that uses decarboxylated CBD to treat children with epilepsy.
These new cannabinoids are sure to attract attention from both patients and investors alike. As the medical marijuana industry continues
Wrapping Up
The latest in cannabis research and innovation has lead to the discovery of a new class of cannabinoids, known as “new cannabinoids”. These compounds were first isolated from a wild-growing strain of Cannabis sativa known as “Hempseed”.
These newly discovered cannabinoids have shown great potential for treating a wide range of medical conditions, including chronic pain, anxiety, depression, and even cancer. However, due to their unknown origin and lack of FDA regulation, it is difficult to know where these new cannabinoids will be available next.
With such a wide range of potential applications, it is important to keep track of the latest research on these new cannabinoids so that they can be made available to patients as soon as possible.